Patent 9879070 was granted and assigned to MedImmune on January, 2018 by the United States Patent and Trademark Office.
Antibodies and antigen binding fragments thereof directed against Staphylococcus aureus (S. aureus) surface determinant antigens and secreted toxins are disclosed. Methods of detecting, diagnosing and treating S. aureus using the antibodies and antigen binding fragments thereof are also provided.